China approves another COVID-19 vaccine for emergency use
TAIPEI, Taiwan (AP) China has approved a new COVID-19 vaccine for emergency use, one that was developed by the head of its Center for Disease Control, adding a fifth shot to its arsenal.
Gao Fu, the head of Chinas CDC, led the development of a protein subunit vaccine that was approved by regulators last week for emergency use, the Chinese Academy of Sciences Institute of Microbiology said in a statement Monday.
It is the fifth coronavirus vaccine approved in China and the fourth to be given emergency use approval. Three of those given emergency approval have since been approved for general use. All were developed by Chinese companies.
The latest vaccine was developed jointly by Anhui Zhifei Longcom Biopharmaceutical Co. Ltd. and the Chinese Academy of Sciences. The team finished phase 1 and phase 2 clinical trials in October and is currently conducting the last phase of trials in Uzbekistan, Pakistan and Indonesia, according to the statement.
https://apnews.com/article/science-biology-clinical-trials-microbiology-coronavirus-pandemic-25b1d6227a0921038a0dbded2c7dfb6c